Возраст домена | 23 года |
Дата окончания | Истек срок регистрации |
PR | 5 |
ИКС | n/a |
Страниц в Google | 9430 |
Страниц в Яндексе | 43 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 492883 |
Alexa Country | ![]() |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
医療従事者向け|中外製薬
n/a
中外製薬医療従事者向けサイト|日本国内で医療に従事されている皆さま(医師、歯科医師、薬剤師、看護師等)を対象に、医療用医薬品の適正使用のための情報を提供しています。
UTF-8
9.4 КБ
36
2 159 симв.
2 121 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
![]() ![]() |
6 | 7 |
0 | 3848 | ![]() | |
![]() ![]() |
6 | 9 |
0 | 1483 | ![]() | |
![]() ![]() |
4 | 8 |
0 | 113 | ![]() | |
![]() ![]() |
4 | 8 |
1000 | 4981 | ![]() | |
![]() ![]() |
2 | 7 |
50 | 61951 | ![]() | |
![]() ![]() |
2 | n/a | 0 | 1111072 | ![]() | |
![]() |
2 | 3 |
0 | 9102873 | ![]() |
|
![]() ![]() |
2 | 4 |
10 | 116880 | ![]() | |
![]() |
2 | 4 |
10 | 91310 | ![]() | |
![]() ![]() |
2 | 6 |
0 | 2769 | ![]() | |
Еще 40 сайтов после авторизации |
Данные предоставлены сервисом semrush
Данные linkpad ( 17 Апреля 2016 ) | |
Количество ссылок на сайт | 559 |
Количество доменов, которые ссылаются на сайт | 36 |
Количество найденных анкоров | 27 |
Исходящие (внешние) ссылки домена | 0 |
Количество доменов, на которые ссылается сайт | 0 |
Количество исходящих анкоров | 0 |
Внешние ссылки главной страницы ( 5 ) | |
chugai-pharm.co.jp/ | 企業情報 |
chugai-pharm.info/ | 患者さん・ご家族の皆さま |
chugai-pharm.co.jp/rule/WebsiteUse/index.html | ウェブサイト利用規定 |
m3.com/ | こちらをクリック |
chugai-pharm.co.jp/rule/Privacy/index.html | 個人情報の取扱いのご案内 |
Внутренние ссылки главной страницы ( 4 ) | |
#panelA | このページの先頭へ |
chugai-pharm.jp/hc/Satellite?form_id=di_log02000000&pagename... | パスワードを忘れた場合 |
chugai-pharm.jp/hc/Satellite?form_id=di_log03000000&pagename... | <img> |
/pr/popup/index.html | 閲覧推奨環境 |
[ JPRS database provides information on network administration. Its use is ]
[ restricted to network administration purposes. For further information, ]
[ use 'whois -h whois.jprs.jp help'. To suppress Japanese output, add'/e' ]
[ at the end of command, e.g. 'whois -h whois.jprs.jp xxx/e'. ]
Domain Information:
[Domain Name] CHUGAI-PHARM.JP
[Registrant] Chugai Pharmaceutical Co., Ltd.
[Name Server] ns.chugai-pharm.co.jp
[Name Server] ns6.chugai-pharm.co.jp
[Name Server] tokio.mind.ad.jp
[Signing Key]
[Created on] 2001/03/26
[Expires on] 2017/03/31
[Status] Active
[Last Updated] 2016/08/01 11:07:43 (JST)
Contact Information:
[Name] GMO Brights Consulting Inc.
[Email] domain.master@brights.jp
[Web Page] http://www.brightsconsulting.com
[Postal code] 150-8512
[Postal Address] Cerulean Tower, 26-1 Sakuragaoka-cho, Shibuya-ku
[Phone] 03-5784-1069
[Fax] 03-3462-5040
User-agent: *
Disallow: /hc/ss/pr/drug/ava_via0100/guide/em_001.html
Disallow: /hc/ss/pr/drug/ava_via0400/guide/em_001.html
Disallow: /hc/ss/pr/drug/ava_via0100/guide/PDF/em/ChugaiOnc_ava079.pdf
Disallow: /hc/ss/pr/drug/ava_via0400/guide/PDF/em/ChugaiOnc_ava079.pdf
Disallow: /hc/ss/pr/drug/act_via0080/se/tadr/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/act_via0080/se/tadr/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/act_via0080/se/lsadr/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/act_via0080/se/lsadr/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/act_via0080/report/pms/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/act_via0080/report/pms/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/act_via0080/report/sdus/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/act_via0200/se/tadr/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/act_via0200/se/tadr/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/act_via0200/se/lsadr/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/act_via0200/se/lsadr/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/act_via0200/report/pms/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/act_via0200/report/pms/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/act_via0200/report/sdus/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/act_via0400/se/tadr/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/act_via0400/se/tadr/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/act_via0400/se/lsadr/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/act_via0400/se/lsadr/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/act_via0400/report/pms/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/act_via0400/report/pms/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/act_via0400/report/sdus/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/ava_via0100/se/tadr/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/ava_via0100/se/tadr/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/ava_via0100/se/lsadr/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/ava_via0100/se/lsadr/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/ava_via0100/report/pms/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/ava_via0100/report/sdus/PDF/20100823_ava_epmpv.pdf
Disallow: /hc/ss/pr/drug/ava_via0100/report/sdus/PDF/ava_epmpv.pdf
Disallow: /hc/ss/pr/drug/ava_via0100/report/sdus/PDF/ava_tokuteiResult_half.pdf
Disallow: /hc/ss/pr/drug/ava_via0100/report/sdus/PDF/ava_tokutei_gaiyou.pdf
Disallow: /hc/ss/pr/drug/ava_via0100/report/sdus/PDF/ava_tokutei.pdf
Disallow: /hc/ss/pr/drug/ava_via0100/report/sdus/PDF/ava_tokutei_*.pdf$
Disallow: /hc/ss/pr/drug/ava_via0400/se/tadr/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/ava_via0400/se/tadr/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/ava_via0400/se/lsadr/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/ava_via0400/se/lsadr/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/ava_via0400/report/pms/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/ava_via0400/report/sdus/PDF/20100823_ava_epmpv.pdf
Disallow: /hc/ss/pr/drug/ava_via0400/report/sdus/PDF/ava_epmpv.pdf
Disallow: /hc/ss/pr/drug/ava_via0400/report/sdus/PDF/ava_tokuteiResult_half.pdf
Disallow: /hc/ss/pr/drug/ava_via0400/report/sdus/PDF/ava_tokutei_gaiyou.pdf
Disallow: /hc/ss/pr/drug/ava_via0400/report/sdus/PDF/ava_tokutei.pdf
Disallow: /hc/ss/pr/drug/ava_via0400/report/sdus/PDF/ava_tokutei_*.pdf$
Disallow: /hc/ss/pr/drug/xel_fil0300/se/tadr/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/xel_fil0300/se/lsadr/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/tar_fil0025/se/tadr/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/tar_fil0025/se/tadr/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/tar_fil0025/se/lsadr/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/tar_fil0025/se/lsadr/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/tar_fil0025/report/pms/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/tar_fil0025/report/pms/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/tar_fil0025/report/sdus/PDF/*.pdf$
Allow: /hc/ss/pr/drug/tar_fil0025/report/sdus/PDF/tar_tokuteiResult_last10000.pdf
Allow: /hc/ss/pr/drug/tar_fil0025/report/sdus/PDF/tar_pc_tokuteiResult_last800.pdf
Disallow: /hc/ss/pr/drug/tar_fil0025/report/sdus/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/tar_fil0100/se/tadr/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/tar_fil0100/se/tadr/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/tar_fil0100/se/lsadr/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/tar_fil0100/se/lsadr/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/tar_fil0100/report/pms/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/tar_fil0100/report/pms/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/tar_fil0100/report/sdus/PDF/*.pdf$
Allow: /hc/ss/pr/drug/tar_fil0100/report/sdus/PDF/tar_tokuteiResult_last10000.pdf
Allow: /hc/ss/pr/drug/tar_fil0100/report/sdus/PDF/tar_pc_tokuteiResult_last800.pdf
Disallow: /hc/ss/pr/drug/tar_fil0100/report/sdus/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/tar_fil0150/report/pms/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/tar_fil0150/report/pms/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/tar_fil0150/report/sdus/PDF/*.pdf$
Allow: /hc/ss/pr/drug/tar_fil0150/report/sdus/PDF/tar_tokuteiResult_last10000.pdf
Disallow: /hc/ss/pr/drug/tar_fil0150/report/sdus/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/rit_via0010/se/tadr/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/rit_via0010/se/tadr/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/rit_via0010/se/lsadr/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/rit_via0010/se/lsadr/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/rit_via0010/report/pms/PDF/*.pdf$
Allow: /hc/ss/pr/drug/rit_via0010/report/pms/PDF/20150601_rit_epmpv.pdf
Allow: /hc/ss/pr/drug/rit_via0010/report/pms/PDF/20170302_rit_epmpv.pdf
Disallow: /hc/ss/pr/drug/rit_via0010/report/pms/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/rit_via0010/report/sdus/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/rit_via0010/report/sdus/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/rit_via0050/se/tadr/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/rit_via0050/se/tadr/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/rit_via0050/se/lsadr/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/rit_via0050/se/lsadr/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/rit_via0050/report/pms/PDF/*.pdf$
Allow: /hc/ss/pr/drug/rit_via0050/report/pms/PDF/20150601_rit_epmpv.pdf
Allow: /hc/ss/pr/drug/rit_via0050/report/pms/PDF/20170302_rit_epmpv.pdf
Disallow: /hc/ss/pr/drug/rit_via0050/report/pms/back/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/rit_via0050/report/sdus/PDF/*.pdf$
Disallow: /hc/ss/pr/drug/rit_via0050/report/sdus/back/PDF/*.pdf$
Disallow: /hc/ss/pa/sf/act/CD/PDF/sft/outline/*.pdf$
Disallow: /hc/ss/pa/sf/act/CD/PDF/sft/tadr/*.pdf$
Disallow: /hc/ss/pa/sf/act/CD/back/PDF/sft/tadr/*.pdf$
Disallow: /hc/ss/pa/sf/act/CD/PDF/sft/lsadr/*.pdf$
Disallow: /hc/ss/pa/sf/act/CD/back/PDF/sft/lsadr/*.pdf$
Disallow: /hc/ss/pa/sf/act/RA/PDF/sft/outline/*.pdf$
Disallow: /hc/ss/pa/sf/act/RA/PDF/sft/tadr/*.pdf$
Disallow: /hc/ss/pa/sf/act/RA/back/PDF/sft/tadr/*.pdf$
Disallow: /hc/ss/pa/sf/act/RA/PDF/sft/lsadr/*.pdf$
Disallow: /hc/ss/pa/sf/act/RA/back/PDF/sft/lsadr/*.pdf$
Disallow: /hc/ss/pa/sf/act/JIA/PDF/sft/outline/*.pdf$
Disallow: /hc/ss/pa/sf/act/JIA/PDF/sft/tadr/*.pdf$
Disallow: /hc/ss/pa/sf/act/JIA/back/PDF/sft/tadr/*.pdf$
Disallow: /hc/ss/pa/sf/act/JIA/PDF/sft/lsadr/*.pdf$
Disallow: /hc/ss/pa/sf/act/JIA/back/PDF/sft/lsadr/*.pdf$
Disallow: /hc/ss/pa/sf/xel/brA/PDF/sft/outline/*.pdf$
Disallow: /hc/ss/pa/sf/xel/brA/PDF/sft/tadr/*.pdf$
Disallow: /hc/ss/pa/sf/xel/brA/back/PDF/sft/tadr/*.pdf$
Disallow: /hc/ss/pa/sf/xel/brA/PDF/sft/lsadr/*.pdf$
Disallow: /hc/ss/pa/sf/xel/brA/back/PDF/sft/lsadr/*.pdf$
Disallow: /hc/ss/pa/sf/xel/brB/PDF/sft/outline/*.pdf$
Disallow: /hc/ss/pa/sf/xel/brB/PDF/sft/tadr/*.pdf$
Disallow: /hc/ss/pa/sf/xel/brB/back/PDF/sft/tadr/*.pdf$
Disallow: /hc/ss/pa/sf/xel/brB/PDF/sft/lsadr/*.pdf$
Disallow: /hc/ss/pa/sf/xel/brB/back/PDF/sft/lsadr/*.pdf$
Disallow: /hc/ss/pa/sf/xel/clB/PDF/sft/outline/*.pdf$
Disallow: /hc/ss/pa/sf/xel/clB/PDF/sft/tadr/*.pdf$
Disallow: /hc/ss/pa/sf/xel/clB/back/PDF/sft/tadr/*.pdf$
Disallow: /hc/ss/pa/sf/xel/clB/PDF/sft/lsadr/*.pdf$
Disallow: /hc/ss/pa/sf/xel/clB/back/PDF/sft/lsadr/*.pdf$
Disallow: /hc/ss/pa/sf/ava/cl/PDF/sft/scs/*.pdf$
Disallow: /hc/ss/pa/sf/ava/cl/PDF/sft/pms/*.pdf$
Disallow: /hc/ss/pa/sf/ava/cl/PDF/sft/outline/*.pdf$
Disallow: /hc/ss/pa/sf/ava/cl/PDF/sft/tadr/*.pdf$
Disallow: /hc/ss/pa/sf/ava/cl/back/PDF/sft/tadr/*.pdf$
Disallow: /hc/ss/pa/sf/ava/cl/PDF/sft/lsadr/*.pdf$
Disallow: /hc/ss/pa/sf/ava/cl/back/PDF/sft/lsadr/*.pdf$
Disallow: /hc/ss/pa/sf/ava/lg/PDF/sft/outline/*.pdf$
Disallow: /hc/ss/pa/sf/ava/lg/PDF/sft/tadr/*.pdf$
Disallow: /hc/ss/pa/sf/ava/lg/back/PDF/sft/tadr/*.pdf$
Disallow: /hc/ss/pa/sf/ava/lg/PDF/sft/lsadr/*.pdf$
Disallow: /hc/ss/pa/sf/ava/lg/back/PDF/sft/lsadr/*.pdf$
Disallow: /hc/ss/pa/sf/tar/lg/PDF/sft/outline/*.pdf$
Disallow: /hc/ss/pa/sf/tar/lg/PDF/sft/tadr/*.pdf$
Disallow: /hc/ss/pa/sf/tar/lg/back/PDF/sft/tadr/*.pdf$
Disallow: /hc/ss/pa/sf/tar/lg/PDF/sft/lsadr/*.pdf$
Disallow: /hc/ss/pa/sf/tar/lg/back/PDF/sft/lsadr/*.pdf$
Disallow: /hc/ss/pa/sf/tar/pc/PDF/sft/outline/*.pdf$
Disallow: /hc/ss/pa/sf/tar/pc/PDF/sft/tadr/*.pdf$
Disallow: /hc/ss/pa/sf/tar/pc/back/PDF/sft/tadr/*.pdf$
Disallow: /hc/ss/pa/sf/tar/pc/PDF/sft/lsadr/*.pdf$
Disallow: /hc/ss/pa/sf/tar/pc/back/PDF/sft/lsadr/*.pdf$
США - Сакраменто - 208.17.90.54
RagingWire Data Centers
Sprint
HTTP/1.0 200 OK
Date: Wed, 17 Oct 2018 01:45:39 GMT
Set-Cookie: ENC_SS_X_JSESSIONID=wUoV9GWxu0iG/2CcW4HQaDKXSBR/m0J0lDj10wlZcjt8SAGWheBJULzgjd625JY57LaME0kb00YJDhenh8A0Zw%3d%3d;Path=/;HttpOnly
Cache-Control: no-store
Last-Modified: Wed, 17 Oct 2018 01:45:40 GMT
Content-Type: text/html;charset=UTF-8
Set-Cookie: ENC_BIGipServerpool2_202.214.81.47_https=Es1BZ8%2b5tnxPLsAIsauw08zkXJcWNwIbTg0a0FkDJQ03wVVQUAYmSS2cB6X%2bP986MAiyMFrXk/iCUAzX4V0U3A%3d%3d; expires=Wed, 17-Oct-2018 02:15:40 GMT; path=/; HttpOnly
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"